Related references
Note: Only part of the references are listed.Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway
Yongwei Wang et al.
CANCER PREVENTION RESEARCH (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Pancreatic Cancer: Current Progress and Future Challenges
S. Perwez Hussain
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive patients with unresectable pancreatic cancer
Johannes-Matthias Lohr et al.
PANCREATOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
Bin Li et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Combination of 12-O-tetradecanoylphorbol-13-acetate with diethyldithiocarbamate markedly inhibits pancreatic cancer cell growth in 3D culture and in immunodeficient mice
Huarong Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Inhibition of Human Pancreatic Cancer Cell Proliferation by Devil's Club Oplopanax horridus and Its Polyacetylene Bioactive Compound
Susan S. C. Cheung et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2015)
Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway
T. Namba et al.
CELL DEATH & DISEASE (2015)
Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2
Wen Yue et al.
ONCOTARGET (2015)
Novel agents for advanced pancreatic cancer
Akintunde Akinleye et al.
ONCOTARGET (2015)
Molecular Targeted Intervention for Pancreatic Cancer
Altaf Mohammed et al.
CANCERS (2015)
Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer
Gang-gang Mu et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway
Yong Pan et al.
INVESTIGATIONAL NEW DRUGS (2015)
Pancreatic Cancer: Progress in Systemic Therapy
Lukas Perkhofer et al.
GASTROINTESTINAL TUMORS (2015)
First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer
Muhammad Wasif Saif et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases
Dannel Yeo et al.
CANCER LETTERS (2014)
Use of herbal medicines and natural products: An alternative approach to overcoming the apoptotic resistance of pancreatic cancer
Lin Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Antiproliferation activity of Devil's club (Oplopanax horridus) and anticancer agents on human pancreatic cancer multicellular spheroids
J. Tai et al.
PHYTOMEDICINE (2014)
Diterpenes from Euphorbia piscatoria: Synergistic Interaction of Lathyranes with Doxorubicin on Resistant Cancer Cells
Mariana A. Reis et al.
PLANTA MEDICA (2014)
Monogalactosyl diacylglycerol, a replicative DNA polymerase inhibitor, from spinach enhances the anti-cell proliferation effect of gemcitabine in human pancreatic cancer cells
Hiroaki Akasaka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer
Michele T. Yip-Schneider et al.
BMC CANCER (2013)
Moringa Oleifera aqueous leaf extract down-regulates nuclear factor-kappaB and increases cytotoxic effect of chemotherapy in pancreatic cancer cells
Liron Berkovich et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Therapeutic Advances in Pancreatic Cancer
Andrew Scott Paulson et al.
GASTROENTEROLOGY (2013)
Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira
Jun Yu et al.
ONCOLOGY REPORTS (2013)
Efficacy of Dimethylaminoparthenolide and Sulindac in Combination With Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer
Michele T. Yip-Schneider et al.
PANCREAS (2013)
Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway
A. Rimmon et al.
BIOCHEMISTRY RESEARCH INTERNATIONAL (2013)
Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets
Ajaikumar B. Kunnumakkara et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Effects of 12-O-tetradecanoylphorbol-13-acetate in combination with gemcitabine on Panc-1 pancreatic cancer cells cultured in vitro or Panc-1 tumors grown in immunodeficient mice
Xi Zheng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Wogonin and Related Natural Flavones Overcome Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Protein Resistance of Tumors by Down-regulation of c-FLIP Protein and Up-regulation of TRAIL Receptor 2 Expression
Jie Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo
Yong-Wei Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Dimethylamino Parthenolide Enhances the Inhibitory Effects of Gemcitabine in Human Pancreatic Cancer Cells
Bryan K. Holcomb et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Enhanced Antitumor Effect of Combination Therapy With Gemcitabine and Guggulsterone in Pancreatic Cancer
Dong-Won Ahn et al.
PANCREAS (2012)
Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?
Jie-Er Ying et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
In Vitro Synergistic Cytotoxic Effect of Triptolide Combined with Hydroxycamptothecin on Pancreatic Cancer Cells
Su-Wen Yang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2011)
Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate
Georgios Kallifatidis et al.
MOLECULAR THERAPY (2011)
Sulforaphane Potentiates the Efficacy of 17-Allylamino 17-Demethoxygeldanamycin Against Pancreatic Cancer Through Enhanced Abrogation of Hsp90 Chaperone Function
Yanyan Li et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2011)
Antitumor effects of the combination of cholesterol reducing drugs
Tadeusz Issat et al.
ONCOLOGY REPORTS (2011)
Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells
Xin-yu Huang et al.
ACTA PHARMACOLOGICA SINICA (2010)
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
G. Bar-Sela et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Molecular Mistletoe Therapy: Friend or Foe in Established Anti-Tumor Protocols? A Multicenter, Controlled, Retrospective Pharmaco-Epidemiological Study in Pancreas Cancer
H. Matthes et al.
CURRENT MOLECULAR MEDICINE (2010)
Chemoprevention strategies for pancreatic cancer
Silvia D. Stan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
Ron Epelbaum et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2010)
Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies
M. Wasif Saif et al.
PHYTOMEDICINE (2010)
被撤回的出版物: Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer (Retracted article. See vol. 78, pg. 5468, 2018)
Sanjeev Banerjee et al.
CANCER RESEARCH (2009)
Cucurbitacin B Induces Apoptosis by Inhibition of the JAK/STAT Pathway and Potentiates Antiproliferative Effects of Gemcitabine on Pancreatic Cancer Cells
Nils H. Thoennissen et al.
CANCER RESEARCH (2009)
被撤回的出版物: 3,3′-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer (Retracted article. See vol. 78, pg. 5467, 2018)
Sanjeev Banerjee et al.
CANCER RESEARCH (2009)
New therapies from old medicines
Shaw T. Chen et al.
NATURE BIOTECHNOLOGY (2008)
Effect of Celecoxib and the Novel Anti-Cancer Agent, Dimethylamino-Parthenolide, in a Developmental Model of Pancreatic Cancer
Michele T. Yip-Schneider et al.
PANCREAS (2008)
Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line
RM Mohammad et al.
PANCREAS (2005)
Determination of the importance of the stereochemistry of psorospermin in topoisomerase II-induced alkylation of DNA and in vitro and in vivo biological activity
IM Fellows et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans retinoic acid on the growth of cultured human pancreas cancer cells and pancreas tumor xenografts in immunodeficient mice
GE Avila et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-κB pathway in pancreatic carcinoma cells
MT Yip-Schneider et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment
RE Schwarz et al.
CANCER LETTERS (2003)
Guggulsterone: an old approach to a new problem
CJ Sinal et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
The development of strategies for terpenoid structure determination
JR Hanson
NATURAL PRODUCT REPORTS (2001)
Share Paper
